Laurion Capital Management LP Verona Pharma PLC Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.48 - $17.02 $1.94 Million - $2.87 Million
168,802 Added 19.14%
1,050,842 $15.2 Million
Q1 2024

May 15, 2024
BUY
$15.3 - $20.24 $4.57 Million - $6.04 Million
298,582 Added 51.17%
882,040 $14.2 Million
Q4 2023

Feb 14, 2024
BUY
$11.94 - $20.47 $6.97 Million - $11.9 Million
583,458 New
583,458 $11.6 Million

Others Institutions Holding VRNA

# of Institutions
166
Shares Held
68.7M
Call Options Held
704K
Put Options Held
685K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email